Learn about new requirements and reimbursement changes.
Gain expert insights into the potential impact of major changes to reimbursement and regulations.
Understand the implications of the potential elimination of the inpatient-only (IPO) list.
Learn about potential changes to MS-DRGs in the 2026 Outpatient Prospective Payment System proposed rule.
Gain insights into CMS' proposals for the 340B drug discount program.
Understand how proposals for professional reimbursement could have far-reaching affects on clinics and hospitals.
Learn how revenue integrity leaders are applying and preparing for advanced technology.
Apply these lessons to reduce denials and support efficient processes.
One of the most common errors seen in skin substitute claims is the inappropriate application of drug waste modifiers, which are as follows:
Review recent billing and coding updates concerning critical care, telehealth, and other evaluation and management (E/M) services.
